advertisement

Topcon

Lambert SR 11

Showing records 1 to 11 | Display all abstracts from Lambert SR

86821 Oculocerebrorenal syndrome of Lowe: Survey of ophthalmic presentations and management
Ma X
European Journal of Ophthalmology 2020; 0: 1120672120920544
86740 Globe Axial Length Growth at Age 10.5 Years in the Infant Aphakia Treatment Study
Wilson ME
American Journal of Ophthalmology 2020; 216: 147-155
86821 Oculocerebrorenal syndrome of Lowe: Survey of ophthalmic presentations and management
Ning K
European Journal of Ophthalmology 2020; 0: 1120672120920544
86740 Globe Axial Length Growth at Age 10.5 Years in the Infant Aphakia Treatment Study
Trivedi RH; Weakley DR
American Journal of Ophthalmology 2020; 216: 147-155
86821 Oculocerebrorenal syndrome of Lowe: Survey of ophthalmic presentations and management
Jabbehdari S
European Journal of Ophthalmology 2020; 0: 1120672120920544
86740 Globe Axial Length Growth at Age 10.5 Years in the Infant Aphakia Treatment Study
Cotsonis GA
American Journal of Ophthalmology 2020; 216: 147-155
86821 Oculocerebrorenal syndrome of Lowe: Survey of ophthalmic presentations and management
Prosseda PP; Hu Y
European Journal of Ophthalmology 2020; 0: 1120672120920544
86740 Globe Axial Length Growth at Age 10.5 Years in the Infant Aphakia Treatment Study
Lambert SR
American Journal of Ophthalmology 2020; 216: 147-155
86821 Oculocerebrorenal syndrome of Lowe: Survey of ophthalmic presentations and management
Shue A
European Journal of Ophthalmology 2020; 0: 1120672120920544
86740 Globe Axial Length Growth at Age 10.5 Years in the Infant Aphakia Treatment Study

American Journal of Ophthalmology 2020; 216: 147-155
86821 Oculocerebrorenal syndrome of Lowe: Survey of ophthalmic presentations and management
Lambert SR; Sun Y
European Journal of Ophthalmology 2020; 0: 1120672120920544

Issue 21-2

Change Issue


advertisement

Nidek